• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值在预测川崎病预后中的价值。

Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.

作者信息

Ha Kee-Soo, Lee Jeehoo, Jang Gi Young, Lee JungHwa, Lee Kwang Chul, Son Chang Sung, Lee Joo Won

机构信息

Department of Pediatrics, Korea University Medical Center, Guro Hospital, Seoul, Korea.

Department of Pediatrics, Korea University Medical Center, Ansan Hospital, Seoul, Korea.

出版信息

Am J Cardiol. 2015 Jul 15;116(2):301-6. doi: 10.1016/j.amjcard.2015.04.021. Epub 2015 Apr 18.

DOI:10.1016/j.amjcard.2015.04.021
PMID:25975725
Abstract

Total and differential leukocyte counts are useful inflammatory biomarkers. The ability of the neutrophil-to-lymphocyte ratio (NLR) to predict outcomes in patients with Kawasaki disease (KD) was assessed in this study. All patients with KD who underwent consecutive complete blood count analyses during the acute febrile phase before intravenous immunoglobulin (IVIG), 2 days after IVIG regardless of defervescence, and 3 to 4 weeks after defervescence were enrolled. NLR was calculated by dividing the neutrophil count by the lymphocyte count. NLR values that best predicted IVIG resistance and the development of coronary artery abnormalities were determined by receiver-operating characteristic curve and multivariate analyses. Of the 587 patients with KD, 222 were IVIG resistant. IVIG-resistant patients had higher NLRs than IVIG-responsive patients. The best NLR cut-off values during the acute febrile phase and 2 days after IVIG for predicting IVIG resistance were 5.49 (p <0.001) and 1.26 (p <0.001), respectively. Sixty-two patients developed coronary artery abnormalities; 47 had coronary dilatation, and 15 had aneurysms. Patients with aneurysms, but not patients with dilatation, had higher NLRs than patients without coronary artery abnormalities. The best NLR cut-off value 2 days after IVIG for predicting aneurysm development was 1.01 (p <0.001). Multivariate analysis revealed that the NLR 2 days after IVIG independently predicted coronary aneurysm development (p = 0.03) and IVIG resistance (p <0.001). In conclusion, the NLR can be used for risk stratification in patients with KD. An NLR 2 days after IVIG that exceeded 1 was predictive of coronary aneurysm development and IVIG resistance.

摘要

白细胞总数及分类计数是有用的炎症生物标志物。本研究评估了中性粒细胞与淋巴细胞比值(NLR)预测川崎病(KD)患者预后的能力。纳入了所有在静脉注射免疫球蛋白(IVIG)前急性发热期、IVIG注射后2天(无论是否退热)以及退热后3至4周接受连续全血细胞计数分析的KD患者。NLR通过中性粒细胞计数除以淋巴细胞计数来计算。通过受试者操作特征曲线和多变量分析确定最能预测IVIG抵抗和冠状动脉异常发生的NLR值。在587例KD患者中,222例对IVIG抵抗。IVIG抵抗患者的NLR高于IVIG反应性患者。急性发热期和IVIG注射后2天预测IVIG抵抗的最佳NLR临界值分别为5.49(p<0.001)和1.26(p<0.001)。62例患者出现冠状动脉异常;47例有冠状动脉扩张,15例有动脉瘤。有动脉瘤的患者,而非有扩张的患者,其NLR高于无冠状动脉异常的患者。IVIG注射后2天预测动脉瘤发生的最佳NLR临界值为1.01(p<0.001)。多变量分析显示,IVIG注射后2天的NLR可独立预测冠状动脉瘤的发生(p = 0.03)和IVIG抵抗(p<0.001)。总之,NLR可用于KD患者的风险分层。IVIG注射后2天NLR超过1可预测冠状动脉瘤的发生和IVIG抵抗。

相似文献

1
Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.中性粒细胞与淋巴细胞比值在预测川崎病预后中的价值。
Am J Cardiol. 2015 Jul 15;116(2):301-6. doi: 10.1016/j.amjcard.2015.04.021. Epub 2015 Apr 18.
2
High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.高中性粒细胞与淋巴细胞比值与难治性川崎病相关。
Pediatr Int. 2017 Jun;59(6):669-674. doi: 10.1111/ped.13240. Epub 2017 Apr 12.
3
[Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].[中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在预测川崎病静脉注射免疫球蛋白敏感性中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Apr;19(4):410-413. doi: 10.7499/j.issn.1008-8830.2017.04.010.
4
The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合预测川崎病静脉注射免疫球蛋白抵抗的作用。
J Pediatr. 2016 Nov;178:281-284.e1. doi: 10.1016/j.jpeds.2016.07.035. Epub 2016 Aug 12.
5
The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合作为川崎病患者静脉注射免疫球蛋白抵抗的新型预测指标:一项多中心研究
Heart Vessels. 2020 Oct;35(10):1463-1472. doi: 10.1007/s00380-020-01622-z. Epub 2020 May 24.
6
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉瘤的预测因素
Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.
7
Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.C反应蛋白/白蛋白比值在预测静脉注射免疫球蛋白抵抗性川崎病中的价值——来自中国多机构研究的数据
Int Immunopharmacol. 2020 Dec;89(Pt A):107037. doi: 10.1016/j.intimp.2020.107037. Epub 2020 Nov 23.
8
A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合应用及其他风险评分系统对川崎病静脉注射免疫球蛋白(IVIG)抵抗的预测效度比较。
PLoS One. 2017 May 23;12(5):e0176957. doi: 10.1371/journal.pone.0176957. eCollection 2017.
9
Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.炎症细胞因子作为川崎病患者对静脉注射免疫球蛋白治疗抵抗的预测因子。
Int J Rheum Dis. 2013 Apr;16(2):168-72. doi: 10.1111/1756-185X.12082.
10
Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.治疗前后川崎病患者静脉注射免疫球蛋白抵抗和冠状动脉瘤的实验室预测因子评估。
Clin Rheumatol. 2023 Jan;42(1):167-177. doi: 10.1007/s10067-022-06366-x. Epub 2022 Sep 21.

引用本文的文献

1
Neutrophil heterogeneity in Kawasaki disease and multisystem inflammatory syndrome in children.川崎病和儿童多系统炎症综合征中的中性粒细胞异质性
Pediatr Res. 2025 Jun 19. doi: 10.1038/s41390-025-04200-z.
2
Dynamic changes of serum matrix metalloproteinases and tissue inhibitors in Kawasaki disease: implications for coronary artery lesions persistence.川崎病血清基质金属蛋白酶和组织抑制剂的动态变化:对冠状动脉病变持续存在的影响
Ital J Pediatr. 2025 Jun 2;51(1):169. doi: 10.1186/s13052-025-01990-0.
3
Values of prognostic nutritional index for predicting Kawasaki disease: a systematic review and meta-analysis.
预测川崎病的预后营养指数值:一项系统评价和荟萃分析
Front Nutr. 2024 Feb 2;11:1305775. doi: 10.3389/fnut.2024.1305775. eCollection 2024.
4
A machine learning model for distinguishing Kawasaki disease from sepsis.用于鉴别川崎病与脓毒症的机器学习模型。
Sci Rep. 2023 Aug 2;13(1):12553. doi: 10.1038/s41598-023-39745-8.
5
Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease.建立川崎病持续性冠状动脉瘤的早期识别预测模型。
BMC Pediatr. 2023 Feb 16;23(1):79. doi: 10.1186/s12887-023-03876-8.
6
Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications.新型冠状病毒感染后发生的川崎病:炎症反应更强但心脏并发症未增加。
Front Pediatr. 2022 Nov 17;10:1036306. doi: 10.3389/fped.2022.1036306. eCollection 2022.
7
Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-Analysis.中性粒细胞与淋巴细胞比值作为川崎病冠状动脉异常预测生物标志物的Meta 分析。
Dis Markers. 2022 Oct 11;2022:6421543. doi: 10.1155/2022/6421543. eCollection 2022.
8
Immunophenotyping of peripheral blood cells allows to discriminate MIS-C and Kawasaki disease.外周血细胞的免疫表型分析有助于区分儿童多系统炎症综合征和川崎病。
Transl Med Commun. 2022;7(1):22. doi: 10.1186/s41231-022-00128-2. Epub 2022 Sep 4.
9
Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis.血液炎症标志物对预测川崎病静脉注射免疫球蛋白抵抗的价值:一项系统评价和荟萃分析。
Front Pediatr. 2022 Aug 23;10:969502. doi: 10.3389/fped.2022.969502. eCollection 2022.
10
Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.8个月以下川崎病婴儿冠状动脉瘤的血常规危险因素
BMC Pediatr. 2022 Jan 7;22(1):29. doi: 10.1186/s12887-021-03083-3.